Company news
Easton Pharmaceuticals Inc news in 2013
Easton Pharmaceuticals Inc's news releases, calls and decks from 2013, newest first.
Easton Pharmaceuticals Provides Update on Initiatives Towards Its Cancer Drug "Xilive" and Its Mexican Government Regulatory Filing Submission for "Viorra"
December 11, 2013
Easton Pharmaceuticals Enters Into Cancer Drug Industry by Acquiring Initial Minority Ownership Interest in Experimental Cancer Drug "XILIVE" With 12 Month Option to Purchase Remaining Interest; Preliminary Feedback Extremely Promising
November 6, 2013
Easton Pharmaceuticals Is Provided a Manufacturing, Regulatory Filing Update and Forward Sales Estimates for VIORRA
November 4, 2013
Easton Pharmaceuticals Announces Formal Agreement & Advances Payment to BMV Medica S.A. Towards a Regulatory Filing in Mexico for "Viorra"; Company Anticipates Approval and Initial Sales by End of Second Quarter 2014
October 22, 2013
Easton Pharmaceuticals Announces Application to Obtain a Distributorship License Towards Its Canadian Medical Marijuana Initiatives
October 4, 2013